Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma, Large B-Cell, Diffuse 18Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 7Lymphoma, B-Cell 5Lymphoma 4Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Hematologic Neoplasms 2Neurotoxicity Syndromes 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1HIV Infections 1Disease Progression 1Dendritic Cell Sarcoma, Interdigitating 1Cytokine Release Syndrome 1

Interventions

Cyclophosphamide 76fludarabine phosphate 42Filgrastim 38Peripheral Blood Stem Cell Transplantation 35Radiotherapy 33Cyclosporine 32Busulfan 32Mycophenolic Acid 30Etoposide 30Antilymphocyte Serum 28Whole-Body Irradiation 26Methotrexate 25Rituximab 22Melphalan 21Methylprednisolone 20Vincristine 17Tacrolimus 17Cytarabine 17Cord Blood Stem Cell Transplantation 17Doxorubicin 16Prednisone 15Thiotepa 10Granulocyte Colony-Stimulating Factor 9Carboplatin 8Leucovorin 7fludarabine 6aldesleukin 6Ifosfamide 6sargramostim 5Sirolimus 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dendritic Cell Sarcoma, Interdigitating × axicabtagene ciloleucel × Clear all
NCT07326371 2026-01-08

Glofitamab Combined With CAR-T Therapy in R/R DLBCL

Ruijin Hospital

Phase 2 Not yet recruiting
24 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡